Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study

By Koie Takuya   Ohyama Chikara   Hashimoto Yasuhiro   Hatakeyama Shingo   Yamamoto Hayato   Yoneyama Takahiro   Kamimura Noritaka  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 724-730

Springer Publishing Company

Access to resources Recommend Favorite

The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer

By Wang Linrun   Wu Xiuhua   Huang Mingzhu   Cai Jie   Xu Nong   Liu Jian  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 211-218

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

By Maestu I.   Gomez-Aldaravi L.   Torregrosa M.D.   Camps C.   Llorca C.   Bosch C.   Gomez J.   Giner V.   Oltra A.   Albert A.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 345-354

Elsevier

Access to resources Recommend Favorite

Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer

By Iwasaki Kazuhiro   Obara Wataru   Kato Yoichiro   Takata Ryo   Tanji Susumu   Fujioka Tomoaki  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 193-199

Oxford University Press

Access to resources Recommend Favorite

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

By Wang Lin   Huang Ming   Zhang Guo   Xu Nong   Wu Xiu  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 601-607

Springer Publishing Company

Access to resources Recommend Favorite